Anti-human vista antibodies and use thereof
US11603403B2 · kind B2 · utility
0Cited by
170References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 17, 2017 |
| Grant date | Mar 14, 2023 |
| Priority date | — |
| Expiry date | Apr 17, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides agonistic anti-human VISTA antibodies and antibody fragments. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity. These agonist antibodies and antibody fragments are especially useful in the treatment of autoimmunity, allergy, inflammatory conditions, GVHD, sepsis and transplant recipients. Screening assays for identifying these agonists are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.